Forward Pharma Plans $200M IPO To Back Drug Development
Denmark-based biotechnology firm Forward Pharma A/S filed Monday to raise as much as $200 million in an initial public offering in the U.S. to help fund the clinical development of multiple...To view the full article, register now.
Already a subscriber? Click here to view full article